Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ICU

SeaStar Medical (ICU)

SeaStar Medical Holding Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ICU
FechaHoraFuenteTítuloSímboloCompañía
14/05/202415:05GlobeNewswire Inc.SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
30/04/202407:30GlobeNewswire Inc.SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
17/04/202415:00GlobeNewswire Inc.SeaStar Medical Reports 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
11/04/202407:30GlobeNewswire Inc.SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
27/03/202407:30GlobeNewswire Inc.SeaStar Medical to Restate Financials, Sets Business Update Call for April 17NASDAQ:ICUSeaStar Medical Holding Corporation
12/03/202407:30GlobeNewswire Inc.SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
11/03/202415:05GlobeNewswire Inc.SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024NASDAQ:ICUSeaStar Medical Holding Corporation
27/02/202407:30GlobeNewswire Inc.Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
22/02/202406:58GlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:ICUSeaStar Medical Holding Corporation
22/02/202406:53GlobeNewswire Inc.FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
01/02/202407:30GlobeNewswire Inc.SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device TechnologyNASDAQ:ICUSeaStar Medical Holding Corporation
26/01/202407:05GlobeNewswire Inc.SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-MarketNASDAQ:ICUSeaStar Medical Holding Corporation
11/01/202415:05GlobeNewswire Inc.SeaStar Medical Appoints David A. Green as Chief Financial OfficerNASDAQ:ICUSeaStar Medical Holding Corporation
09/01/202407:30GlobeNewswire Inc.SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical IndicationsNASDAQ:ICUSeaStar Medical Holding Corporation
28/12/202307:30GlobeNewswire Inc.SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
13/12/202307:30GlobeNewswire Inc.SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical ExpertsNASDAQ:ICUSeaStar Medical Holding Corporation
14/11/202315:04GlobeNewswire Inc.SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
31/10/202307:00GlobeNewswire Inc.Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic DeviceNASDAQ:ICUSeaStar Medical Holding Corporation
30/10/202307:00GlobeNewswire Inc.FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
18/10/202307:30GlobeNewswire Inc.FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal SyndromeNASDAQ:ICUSeaStar Medical Holding Corporation
05/10/202307:30GlobeNewswire Inc.SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023NASDAQ:ICUSeaStar Medical Holding Corporation
03/10/202315:05GlobeNewswire Inc.SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device ExemptionNASDAQ:ICUSeaStar Medical Holding Corporation
29/09/202307:30GlobeNewswire Inc.FDA Grants Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device for Cardiorenal SyndromeNASDAQ:ICUSeaStar Medical Holding Corporation
21/09/202308:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
30/08/202315:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICUSeaStar Medical Holding Corporation
29/08/202307:00GlobeNewswire Inc.Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medical’s Selective Cytopheretic Device Published in the Journal Blood PurificationNASDAQ:ICUSeaStar Medical Holding Corporation
22/08/202307:00GlobeNewswire Inc.SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern TimeNASDAQ:ICUSeaStar Medical Holding Corporation
17/08/202316:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICUSeaStar Medical Holding Corporation
15/08/202315:45Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ICUSeaStar Medical Holding Corporation
14/08/202316:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICUSeaStar Medical Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:ICU